Jun. 12 at 4:35 PM
$GUTS While we were sleeping, Fractyl just landed a massive heavy hitter to lead commercialization (including launch and reimbursement) and strengthen their M&A Team.
https://ir.fractyl.com/news-releases/news-release-details/fractyl-health-appoints-mike-zumdahl-senior-vice-president
A few highlights:
1) Led Global Health Economics, Market Access, and Government Affairs at Inari Medical before its acquisition by Stryker for approximately
$4.9 billion in February 2025, helping create one of medtech’s most successful market access build-outs for a novel procedural category.
2) Spent nearly a decade at Novo Nordisk (
$NVO) in roles of increasing responsibility, including National Accounts and Government Payers, where he contributed to the company's Health Economics and Outcomes Research strategy and value-based contracting for GLP-1 therapies.
3) Started as a sales representative at
$GSK,
4) Most recently, was President of Commercial Access Partners, advising medtech companies on go-to-market strategy, health economics, and reimbursement.
Exciting times
$GUTS
#FractylForward
$XBI
